Skip to main content

Tetrabenazine Dosage

Medically reviewed by Drugs.com. Last updated on Nov 24, 2023.

Applies to the following strengths: 12.5 mg; 25 mg

Usual Adult Dose for Huntington Disease


Comments:

Use: Chorea associated with Huntington's disease.

Renal Dose Adjustments

Data not available.

Liver Dose Adjustments

Use is contraindicated.

Dose Adjustments

CYP450 Poor Metabolizers:


CYP450 Extensive and Intermediate Metabolizers:

Concomitant Use with Strong CYP450 2D6 Inhibitors:

Occurrence of Adverse Reaction (e.g., akathisia, restlessness, parkinsonism, depression, insomnia, anxiety, sedation): Reduce the dose and consider discontinuing this drug or initiating other treatment (e.g., antidepressants) if events do not resolve.

Treatment Interruption:

Precautions

US BOXED WARNING:


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available.

Other Comments

Administration Advice:


Storage Requirements:

General:

Monitoring:

Patient Advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.